/
HCAT
$1.96+$0.06 (+3.16%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$140.4M
74M shares
52-week range
$0.96 – $4.13
32% from low
Sector
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.
Exchange
NASDAQ
CS
Borrow rate
0.83%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-53.55
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $112.6M | $154.9M | $188.8M | $241.9M | $276.2M | $295.9M | $306.6M | $311.1M |
| Cost of revenue | $59.9M | $75.3M | $98.1M | $124.4M | $143.0M | $164.1M | $165.8M | $207.0M |
| Gross profit | $52.7M | $79.6M | $90.8M | $117.6M | $133.2M | $131.8M | $140.8M | $104.1M |
| Gross margin | 46.8% | 51.4% | 48.1% | 48.6% | 48.2% | 44.5% | 45.9% | 33.5% |
| R&D | $38.6M | $46.3M | $53.5M | $62.7M | $75.7M | $72.6M | $58.0M | $49.8M |
| Operating income | −$60.1M | −$54.9M | −$96.1M | −$143.7M | −$140.0M | −$126.9M | −$69.8M | −$36.1M |
| EBITDA | −$52.1M | −$47.3M | −$85.9M | −$101.7M | −$82.9M | −$68.3M | −$10.7M | −$110.4M |
| Net income | −$62.0M | −$60.1M | −$115.0M | −$153.2M | −$137.4M | −$118.1M | −$69.5M | −$178.0M |
| Net margin | -55.1% | -38.8% | -60.9% | -63.3% | -49.7% | -39.9% | -22.7% | -57.2% |
| EPS (diluted) | -2.23 | -3.21 | -2.91 | -3.23 | -2.54 | -2.09 | -1.15 | -2.55 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $263M | $0.04 | $-0.21–$0.25 | 4 |
| 2027 | $247M | $0.09 | $-0.32–$0.51 | 4 |
| 2028 | $247M | $0.03 | $0.02–$0.03 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Health Catalyst, Inc Common Stock
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
www.healthcatalyst.com- Employees
- 1,200
- IPO / List date
- Jul 25, 2019
- HQ
- SOUTH JORDAN, UT
Held by traders on TradeandTell
No one on the platform currently holds HCAT.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 217,069 | $275.7K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HCAT yet.
